Remarkable Case: German Receives COVID-19 Vaccine 217 Times
Doctors report an unusual case involving a 62-year-old man from Germany who received 217 Covid vaccinations against medical advice
HOT: » Assessing the Legacy of Bulgaria's "Denkov" Cabinet: Achievements, Failures, and What Comes Next
Novavax vaccine against Covid-19 proved more than 90% effective against a variety of virus variants, the company reported on Monday. The results came from its US-based clinical trial, news wires reported. The study of nearly 30,000 volunteers puts Novavax on track to file for emergency authorisation in the US and elsewhere in the third quarter of 2021.
Novavax's protein-based vaccine candidate was more than 93% effective against the predominant variants of Covid-19 that have been of concern among scientists and public health officials, the company claimed. Protein-based vaccines are a conventional approach that use purified pieces of the virus to spur an immune response.
During the trial, the B.1.1.7 variant first discovered in the UK became the most common variant in the US. Novavax also detected variants of Covid-19 first found in Brazil, South Africa and India among its trial participants, Novavax's head of research and development, Dr. Gregory Glenn, told Reuters.
The vaccine was 91% effective among volunteers at high risk of severe infection and 100% effective in preventing moderate and severe cases of Covid-19. It was roughly 70% effective against Covid-19 variants that Novavax was unable to identify, Glenn said. "Practically speaking, it's very important that the vaccine can protect against a virus that is wildly swinging around," Glenn said.
Novavax said the vaccine was generally well tolerated among participants. Side effects included headache, fatigue and muscle pain and were generally mild. A small number of participants experienced side effects described as severe. Novavax remains on track to produce 100 million doses per month by the end of the third quarter of 2021 and 150 million doses per month in the fourth quarter of 2021, the company said.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
Bulgaria is grappling with a staggering burden of cardiovascular diseases, with more than 6 million new cases and over 1.8 million deaths reported annually
Japanese health authorities have issued a warning as the nation grapples with a significant uptick in potentially fatal strep throat infections, particularly in Tokyo
The World Health Organization (WHO) Regional Office for Europe today released the second volume of the Health Behaviour in School-aged Children (HBSC) study, which focuses on patterns of bullying and peer violence among adolescents across 44 countries and
Statement on World TB Day by WHO Regional Director for Europe, Dr Hans Henri P. Kluge
The Ministry of Finance has disclosed its affirmative stance on allocating resources for covering the entire cost of 56 drugs targeting cardiovascular diseases, such as those addressing hypertension, arrhythmia, and other frequently occurring chronic ailm
During World Sleep Day week, data from recent studies conducted by the Pragmatica Agency and iSleep show that more than 70% of Bulgarians struggle to initiate sleep and experience nighttime awakenings
UN Happiness Report: Bulgaria's Astonishing Leap in Rankings
Bulgaria: 3 Regions With Lowest Life Expectancy - EU Report 2022